SLG
Stanley-Laman Group Portfolio holdings
AUM
$673M
This Quarter Return
+5.38%
1 Year Return
+14.64%
3 Year Return
+60.49%
5 Year Return
+79.33%
10 Year Return
+186.95%
AUM
$407M
AUM Growth
+$407M
(-8.6%)
Cap. Flow
-$50.7M
Cap. Flow
% of AUM
-12.45%
Top 10 Holdings %
Top 10 Hldgs %
19.3%
Holding
282
New
19
Increased
67
Reduced
110
Closed
63
Top Buys
| 1 |
ADAP
Adaptimmune Therapeutics
ADAP
|
$7.67M |
| 2 |
XLRN
Acceleron Pharma Inc.
XLRN
|
$7.16M |
| 3 |
Iovance Biotherapeutics
IOVA
|
$4.24M |
| 4 |
ALBO
Albireo Pharma, Inc. Common Stock
ALBO
|
$1.08M |
| 5 |
Zymeworks
ZYME
|
$887K |
Top Sells
| 1 |
Neurocrine Biosciences
NBIX
|
$8.83M |
| 2 |
BioMarin Pharmaceuticals
BMRN
|
$5.78M |
| 3 |
LJPC
La Jolla Pharmaceutical Company
LJPC
|
$4.57M |
| 4 |
Sangamo Therapeutics
SGMO
|
$1.53M |
| 5 |
SGEN
Seagen Inc. Common Stock
SGEN
|
$966K |
Sector Composition
| 1 | Industrials | 20.92% |
| 2 | Technology | 18% |
| 3 | Healthcare | 15.75% |
| 4 | Materials | 7.84% |
| 5 | Financials | 7.36% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
26
Ball Corp
BALL
$14.3B
| $4.48M | 1.1% |
101,846
-8,851
| -8% | -$389K |
|
27
H.B. Fuller
FUL
$3.29B
| $4.38M | 1.08% |
84,695
-6,447
| -7% | -$333K |
|
|
28
Iovance Biotherapeutics
IOVA
$807M
| $4.24M | 1.04% |
+377,260
| New | +$4.24M |
|
29
Lincoln Electric
LECO
$13.4B
| $4.19M | 1.03% |
44,832
-3,428
| -7% | -$320K |
|
30
Pfizer
PFE
$141B
| $3.96M | 0.97% |
89,870
-1,131
| -1% | -$49.8K |
|
31
MDU Resources
MDU
$3.33B
| $3.91M | 0.96% |
152,056
-12,343
| -8% | -$317K |
|
32
Cisco
CSCO
$274B
| $3.73M | 0.92% |
76,563
-238
| -0.3% | -$11.6K |
|
33
Ingredion
INGR
$8.31B
| $3.71M | 0.91% |
35,324
-2,766
| -7% | -$290K |
|
|
BERY
34
DELISTED
Berry Global Group, Inc.
BERY
| $3.35M | 0.82% |
69,149
-7,104
| -9% | -$344K |
|
35
Honeywell
HON
$139B
| $3.1M | 0.76% |
18,620
-435
| -2% | -$72.4K |
|
36
Fortune Brands Innovations
FBIN
$7.02B
| $3.09M | 0.76% |
59,087
-5,273
| -8% | -$276K |
|
|
PX
37
DELISTED
Praxair Inc
PX
| $2.95M | 0.72% |
18,351
-618
| -3% | -$99.3K |
|
38
RTX Corp
RTX
$212B
| $2.94M | 0.72% |
21,039
-462
| -2% | -$64.6K |
|
39
CyberArk
CYBR
$22.8B
| $2.83M | 0.69% |
35,382
+511
| +1% | +$40.8K |
|
40
IBM
IBM
$227B
| $2.77M | 0.68% |
18,288
-653
| -3% | -$98.7K |
|
41
Akebia Therapeutics
AKBA
$833M
| $2.66M | 0.65% |
301,182
-40,307
| -12% | -$356K |
|
42
Boeing
BA
$177B
| $2.47M | 0.61% |
6,649
-53
| -0.8% | -$19.7K |
|
43
Exelon
EXC
$44.1B
| $2.46M | 0.61% |
56,422
-1,132
| -2% | -$49.4K |
|
44
Paychex
PAYX
$50.2B
| $2.45M | 0.6% |
33,192
-688
| -2% | -$50.7K |
|
45
CNA Financial
CNA
$13.4B
| $2.41M | 0.59% |
52,773
-812
| -2% | -$37.1K |
|
46
Walmart
WMT
$774B
| $2.41M | 0.59% |
25,623
-716
| -3% | -$67.2K |
|
47
Truist Financial
TFC
$60.4B
| $2.33M | 0.57% |
47,992
-922
| -2% | -$44.8K |
|
48
Gilead Sciences
GILD
$140B
| $2.27M | 0.56% |
29,433
-297
| -1% | -$22.9K |
|
49
CME Group
CME
$96B
| $2.25M | 0.55% |
13,215
-219
| -2% | -$37.3K |
|
50
Verizon
VZ
$186B
| $2.22M | 0.55% |
41,630
-6,726
| -14% | -$359K |
|